Inhibition of angiogenesis in the treatment of tumors

• Authors: K. Ostrowski , A. Kinsner
• Languages of publication: EN

Abstracts

EN

Angiogenesis is essential for tumor progression, growth and metastases. Many substances present in a normal organism can inhibit or stimulate the process of new vessel formation in tumors. The use of natural or synthetic angiogenesis inhibitors as anticancer drugs is currently under intense investigation. Such agents can have lower toxicity and are less likely to generate drug resistance than conventional cytotoxic drugs. Clinical trials are now underway to develop optimum treatment strategies for antiangiogenic drugs. This paper reviews the present achievements in preclinical and clinical studies with antitumor drugs based on inhibitors of angiogenesis.

Keywords

EN

ANGIOGENESISM; CANCER; INHIBITOR

Discipline

• IMMUNOLOGY: IMMUNOLOGY

• Publisher: Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
• Journal: Archivum Immunologiae et Therapiae Experimentalis
• Year: 2001
• Volume: 49
• Issue: 1
• Pages: 27-32

Contributors

author

K. Ostrowski

author

A. Kinsner

• Document Type: REVIEW
• Publication order reference: K. Ostrowski, Department of Histology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland